Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis

Summary

The MUSIC OL study is an open-label extension study, in which all eligible patients having completed the double-blind AC-055B201/MUSIC study as scheduled receive macitentan 10 mg once daily. The study objective is to assess the long-term safety and tolerability of macitentan in patients with idiopathic pulmonary fibrosis (IPF).

Timeline

Start

2011-07-31

Primary completion

2016-08-31

Completion

2016-08-31

Outcome

Outcome not reported

Stopped: “Due to Protocol AC-055B201 (MUSIC) not meeting it's primary end point”

Drugs

Indications